- Home
- PHVS
PHVS
Pharvaris N.V.
as 03-26-2025 11:36am EST
| Founded: | 2015 | Country: | Netherlands |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $41.60 | AVG Volume (30 days): | 45.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.14 - $25.50 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 136.98% | Revenue Growth (next year): | N/A |
Latest Pharvaris N.V. News
PHVS Breaking Stock News: Dive into PHVS Ticker-Specific Updates for Smart Investing
GlobeNewswire
23 days ago
Pharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint Congress
GlobeNewswire
23 days ago
Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025
Simply Wall St.
a month ago
We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Insider Monkey
2 months ago
Why Pharvaris (PHVS) Is Advancing Today
Insider Monkey
2 months ago
Why Is Andreas Halvorsen Bullish On Pharvaris N.V. (PHVS) Now?
GlobeNewswire
2 months ago
Pharvaris Outlines 2025 Strategic Priorities
TipRanks
4 months ago
Pharvaris price target lowered to $46 from $50 at JMP Securities
GlobeNewswire
4 months ago
Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates
Compare PHVS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHVS Pharvaris N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.